Page last updated: 2024-09-03

imatinib mesylate and Liver Neoplasms

imatinib mesylate has been researched along with Liver Neoplasms in 221 studies

Research

Studies (221)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	99 (44.80)	29.6817
2010's	98 (44.34)	24.3611
2020's	24 (10.86)	2.80

Authors

Authors	Studies
Alconchel, F; Fernández, JÁ; Gómez, B; Martínez, J; Ramírez, P	1
Akamaru, Y; Eguchi, S; Hama, N; Harada, S; Ikeshima, R; Munakata, K; Ohashi, H; Ota, H; Shibata, K; Shimaoka, T; Takiuchi, D; Wada, N	1
Hanyu, T; Ichikawa, H; Ishikawa, T; Koyama, Y; Moro, K; Nagahashi, M; Obata, Y; Sakata, J; Shimada, Y; Takizawa, K; Toshikawa, C; Tsuchida, J; Uchida, H; Umezu, H; Wakai, T	1
Antonescu, CR; Chang, JC; Chi, P; Dermawan, JK; Singer, S; Tap, WD; Untch, BR; Vanderbilt, CM	1
Dok I, Y; Eguchi, H; Ikenaga, N; Kurokawa, Y; Makino, T; Nakajima, K; Saito, T; Takahashi, T; Tanaka, K; Yamamoto, K; Yamasaki, M; Yamashita, K	1
Guleria, A; Kumar, P; Kumar, U; Maurya, P; Mishra, N; Nisha, R; Saraf, SA; Singh, P; Singh, S; Tabassum, H	1
Jiang, J; Lai, L; Liu, X; Sun, B; Wang, X; Xiong, J; Yao, Y; Zhang, X	1
Bajt, M; Grgic, D; Moric, T; Pavlek, G; Petrovic, I; Puz, P; Romic, I; Romic, M	1
Hirano, H; Hirota, S; Iwamoto, H; Katayanagi, S; Katsumata, K; Kawachi, S; Makuuchi, Y; Osakabe, H; Sumi, T; Tsuchida, A; Yokoyama, T	1
Aida, T; Miyazawa, K; Miyoshi, T; Ogasawara, T; Sato, S; Shiobara, M; Suda, K; Wakatsuki, K; Yamazaki, K; Yoshioka, S	1
Arab, JP; Barrera, F; Benítez, C; Briceño, E; Cortinez, LI; Dib, M; Fernandes, E; Garrido, M; Guerra, JF; Inzunza, M; Martínez, JA; Rivas, V; Riveros, S; Torres, J	1
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z	1
Acharya, MR; Goel, M; Nadkarni, S; Parray, A; Patel, S; Patkar, S; Shah, A	1
Khatun, M; Long, J; Nazzal, M; Patra, T; Phillips, N; Ray, R; Ray, RB; Steele, R; Sur, S	1
Fujimoto, Y; Okada, T; Ueno, T; Uraoka, M; Yamamura, M	1
Akita, H; Amagasa, H; Ami, K; Ando, M; Chong, JM; Fukuda, A; Ganno, H; Iida, S; Imai, K; Kajiyama, D; Kawaguchi, M; Maeda, F; Motoyama, K; Tokito, F; Yamada, A	1
Cescon, M; Del Gaudio, M; Nannini, M; Pantaleo, MA; Ravaioli, M	1
Christopher, WO; D Anderson, C; J Wynn, J; M Earl, T; Orr, WS; Pham, VL; W Cassell, M	1
Benítez, C; Dib, M; Garrido, M; Inzunza, M; Martínez, JA	1
Ikeda, T; Ito, T; Koike, K; Kubota, H; Takayanagi, Y	1
Shamaa, MM	1
Guleria, A; Kumar, P; Kumar, U; Maurya, P; Mishra, N; Nisha, R; Saha, S; Saraf, SA; Singh, P; Singh, S	1
Araki, K; Harimoto, N; Hoshino, T; Ishii, N; Kakizaki, S; Kudo, T; Masuda, T; Naganuma, A; Ogawa, T; Ogawa, Y; Shirabe, K; Suzuki, Y; Tateno, K; Tateyama, Y; Uehara, S; Yasuoka, H	1
Han, Y; Ma, Z	1
Ando, S; Fujiwara, Y; Kamei, R; Kitamura, Y; Matsui, H; Nagano, H; Sakamoto, K; Yamamoto, T; Yoshino, S	1
Chen, SJ; Huang, CK; Liu, F; Luo, C; Qian, H; Xiao, MC; Xie, WF; Yan, FZ; Zhang, X; Zheng, BN	1
Ikeda, M; Inoue, M; Kajikawa, R; Kajiwara, R; Miyamoto, K; Ohmori, I; Sadamoto, S; Sawada, H; Shishida, M; Takahashi, T; Toyota, K; Watanabe, A	1
Aubry, S; Braunstein, C; Chaigneau, L; Delroeux, D; Hubert, P; Kalbacher, E; Marie, B; Meynard, G; Mihai, I; Sirveaux, F	1
Friberg, LE; Krishnan, SM; Mathijssen, R; Ruggiero, A; Schiavon, G; Schindler, E	1
Cheng, KS; Yang, CY	1
Babić, N; Bohnec, S; Budimir, I; Hrabar, D; Nikolić, M; Pavić, I	1
Fan, LQ; Hao, YJ; Jia, N; Li, B; Li, Y; Liang, H; Liang, XB; Liu, Y; Ma, ZX; Shi, YN; Tan, BB; Wang, D; Wang, LL; Wang, LP; Wang, ZH; Zhang, L; Zhang, ZD; Zhao, Q; Zhao, XF	1
Al Asad, O; Alawin, I; Nawgiri, R; Saraireh, H; Tayyem, O	1
Chen, YB; Feng, XY; Guo, J; Liu, XC; Ma, MZ; Qiu, HB; Sun, XW; Zhou, ZG; Zhou, ZW	1
Fu, Y; Liang, J; Lin, L; Wei, X; Xu, W	1
Kammerer, S; Küpper, JH; Nowak, E	1
Alves, AP; Alves, MG; Botelho, MF; Maia, CJ; Mamede, AC; Oliveira, PF; Rocha, SM	1
Fu, YY; Hu, HJ; Li, FY	1
Cowie, F; Grosset, DG; Watson-Fargie, T; White, J	1
Honda, T; Kabashima, K; Nomura, M; Otsuka, A; Yamashita, C	1
Bi, X; Cai, J; Chen, Q; Huang, Z; Li, C; Li, Z; Yang, H; Zhang, Y; Zhao, H; Zhao, J; Zhou, J	1
Deguchi, S; Hirakawa, K; Hori, T; Iimori, N; Ishikawa, T; Masuda, G; Nakao, S; Nakata, B; Ohira, M; Sakimura, C; Tendo, M	1
Kong, J; Li, Y; Qiu, Y; Wang, W; Zhang, H	1
Goto, T; Ishida, R; Ku, Y; Miyashita, M; Muramatsu, S; Sendo, H; Tsukamoto, Y; Yamazaki, T; Yasuda, T	1
Abdel-Mageed, AM; Al-Tamimi, J; Alhazza, IM; Aman, S; Ebaid, H; Hassan, I	1
Ali, CM; Chadli, D; Ibtissem, B; Leila, GE; Ramzi, N; Wejih, DM	1
Abu Sammour, D; Erich, K; Findeisen, P; Geisel, A; Hohenberger, P; Hopf, C; Marsching, C; Marx, A; Rabe, JH; Ramallo Guevara, C; Schulz, S	1
Chen, MF; Chiang, KC; Fu, CJ; Jan, YY; Yeh, CN; Yen, TC	1
Aupérin, A; Boudabous, S; Debaere, T; Deschamps, F; Domont, J; Farouil, G; Hakimé, A; Le Cesne, A	1
Atkinson, HD; Colović, N; Colović, R; Grubor, N; Matić, S; Micev, M	1
Jia, J; Lu, HS; Pan, YL; Tao, DY; Zheng, S	1
Belgaumkar, AP; Cananzi, FC; Lorenzi, B; Mudan, S	1
Gupta, SK; Louis, AR; Sharma, A; Singh, S	1
Fujisawa, T; Matsumoto, Y; Nishizawa, A; Takata, M	1
Hanada, N; Hori, K; Kawata, K; Okamura, S; Tomiyama, N	1
Beck, MY; Kang, YK; Ryoo, BY; Ryu, MH; Yoo, C; Yoon, S	1
An, HJ; Kang, YK; Kim, BS; Kim, KH; Oh, ST; Ryoo, BY; Ryu, MH; Sohn, BS; Yook, JH; Yu, CS	1
Dourthe, LM; Heymann, S; Imperiale, A; Sauer, B; Schlund-Schoettel, E	1
Ebisui, C; Fukuchi, N; Kato, R; Kinuta, M; Makino, S; Murata, K; Nishigaki, T; Okada, K; Okamura, S; Owada, Y; Tamai, M; Wada, Y; Yanagisawa, T; Yokouchi, H	1
Ebisui, C; Kinuta, M; Murakami, M; Murata, K; Nakagomi, N; Okada, K; Okamura, S; Tamai, M	1
Barry, PA; Bekers, DJ; Kloth, J; Krestin, GP; Mathijssen, RH; Ruggiero, A; Schiavon, G; Schöffski, P; Sleijfer, S; Verweij, J	1
Bauer, S; Casali, PG; Cats, A; Fiore, M; Fumagalli, E; Gronchi, A; Hohenberger, P; Hoiczyk, M; Kerst, M; Miceli, R; Nguyen, BP; Nyckowski, P; Rutkowski, P; Siedlecki, JA; Treckmann, J; van Coevorden, F	1
Calipel, A; De La Fouchardière, A; Landreville, S; Mascarelli, F; Mouriaux, F; Penel, N; Rivoire, M	1
Kanehara, I; Kitayama, K; Nishino, H; Nomura, S; Teraoka, H; Toyokawa, T	1
Liang, H	1
Banks, S; Edmiston, K; Liotta, L; Parasido, E; Petricoin, E; Pierobon, M; Pin, E; Reeder, A; Silvestri, A; Spira, A	1
Beaune, P; de Waziers, I; Favre, A; Figg, WD; Kiehl, P; McMullen, J; Montemurro, M; Narjoz, C; Rochat, B	1
Akanuma, N; Akutsu, Y; Hoshino, I; Isozaki, Y; Kono, T; Maruyama, T; Matsubara, H; Nakano, A; Shuto, K; Uesato, M	1
Hayakumo, T; Ikura, Y; Iwai, Y; Kadota, C; Shigaki, Y	1
Alago, W; Brown, KT; Cornelis, F; Covey, A; Erinjeri, JP; Getrajdman, GI; Litchman, T; Maybody, M; Sofocleous, CT; Solomon, SB; Takaki, H	1
Belgaumkar, A; Cananzi, FC; Lorenzi, B; Mudan, S	1
Chen, H; Chen, J; Chen, Z; Shen, C; Yin, Y; Zhang, B	1
Egawa, C; Goto, T; Hashimoto, T; Ishida, T; Kagawa, Y; Kato, T; Katsura, Y; Kimura, K; Kuroda, Y; Kusama, H; Matsushita, K; Morimoto, Y; Nakahira, S; Nakatsuka, S; Nitta, K; Ohmura, Y; Ohzono, K; Okishiro, M; Sakisaka, H; Sato, Y; Takeda, Y; Takeno, A; Tamura, S; Taniguchi, H	1
Doki, Y; Hara, H; Kurokawa, Y; Miyata, H; Miyazaki, Y; Mori, M; Nakajima, K; Takahashi, T; Takiguchi, S; Yamasaki, M	1
Doki, Y; Kurokawa, Y; Miyata, H; Miyazaki, Y; Mori, M; Nakajima, K; Nakatsuka, R; Takahashi, T; Takiguchi, S; Yamasaki, M	1
Lin, XK; Liu, XS; Shou, CH; Sun, JY; Yang, WL; Yu, JR; Zhang, Q	1
Aloia, TA; Brudvik, KW; Conrad, C; Cormier, JN; Feig, BW; Hunt, KK; Patel, SH; Roland, CL; Torres, KE; Vauthey, JN	1
Glimelius, B; Golla, SS; Jonasson, M; Lubberink, M; Nygren, P; Rubin, K; Sörensen, J	1
Bose, SK; Di Bisceglie, AM; Kwon, YC; Meyer, K; Ray, R; Ray, RB; Steele, R	1
Ahmad, A; Katz, SC; Libbey, NP; Somasundar, P	1
Fujita, J; Hirota, S; Imamura, H; Kishi, K; Nishida, T; Sato, S; Takagi, M; Takahashi, T; Tsujinaka, T; Yamamoto, K	1
Hasegawa, J; Hirota, M; Ikenaga, M; Kameda, C; Kawabata, R; Koga, C; Miwa, H; Murakami, M; Noura, S; Ozato, Y; Shimizu, J; Yoshikawa, M	1
Komatsu, T; Nomura, S; Ogasawara, T; Shida, T; Takahara, Y; Takahashi, M; Uno, H	1
de Jong, KP; de Wilt, JH; Nagtegaal, ID; Seesing, MF; Tielen, R; van Coevorden, F; van Hillegersberg, R; Verhoef, C	1
Fujita, J; Hirota, S; Masuzawa, T; Nishida, T; Sato, S; Takagi, M; Takahashi, T; Tsujinaka, T; Yamamoto, K; Yamashita, Y	1
Kim, CW; Kim, HY; Seo, KJ; Whang, IY; Won, HS	1
Chen, T; Chen, Z; Feng, X; Li, G; Li, Y; Qiu, H; Sun, X; Tao, K; Yu, J; Zhang, P; Zhou, Z	1
Hata, Y; Hirai, T; Ikawa, O; Ishikawa, T; Kagimura, T; Kanda, T; Masuzawa, T; Mochizuki, I; Nishida, T; Ojima, H; Sodeyama, H; Takagane, A	1
Alakus, H; Brunold, M; Bruns, CJ; Coutelle, O; Goede, V; Hacker, UT; Hallek, M; Kashkar, H; Liwschitz, M; Loges, S; Quaas, A; Schiffmann, LM; Stippel, D; Wroblewski, M	1
Ishizaki, M; Katoh, T; Komine, C; Matsumoto, A; Morinaga, N; Nakamura, T; Nakazato, K; Saito, H; Shitara, Y; Tanaka, N	1
Aragüés, R; Martín, B; Oliva, B; Sanz, R; Sierra, A	1
Hosone, M; Liu, A; Maeda, S; Maruyama, H; Matsutani, T; Miyamoto, M; Sasajima, K; Suzuki, S; Tajiri, T; Watanabe, H; Yokoyama, T	1
Malfertheiner, P; Treiber, G; Wex, T	1
Siegel, A	1
Battistella, M; Dubertret, L; Frémont, G; Gornet, JM; Vignon-Pennamen, MD; Viguier, M	1
Asano, S; Dairaku, N; Hiwatashi, N; Ikeya, S; Kojima, Y; Koshita, S; Kusano, M; Nakayama, H; Ojima, T; Shimada, N; Sugai, Y; Yamagiwa, T; Yokoyama, A	1
Akiyama, T; Higashida, M; Hirabayashi, Y; Hirai, T; Hironaka, K; Ikeda, M; Kawabe, Y; Kubota, H; Matsumoto, H; Murakami, H; Oka, Y; Okawaki, M; Okumura, H; Tsunoda, T; Urakami, A; Yamaguchi, Y; Yamamura, M; Yamashita, K	1
Albiter, M; Bonvalot, S; Dromain, C; Le Cesne, A; Le Péchoux, C; Mabille, M; Shapeero, LG; Terrier, P; Vanel, D	1
Barzilai, M; Domachevsky, L; Peled, N	1
Kayaselçuk, F; Koç, Z; Ulusan, S	1
Altavilla, G; Arrigo, C; Pitini, V	1
Astorino, M; Azzaroli, F; Biasco, G; Catena, F; Di Battista, M; Di Scioscio, V; Lolli, C; Maleddu, A; Pantaleo, MA; Santini, D; Saponara, M	1
Jain, P; Jha, AK; Rai, RR	1
Kapoor, S	1
Bovée, JV; Gelderblom, H; Hogendoorn, PC; Kroep, JR; van der Molen, AJ	1
Bensimhon, D; Boudiaf, M; Dray, X; Duchat, F; Fargeaudou, Y; Hamzi, L; Idy-Peretti, I; Martin-Grivaud, S; Nemeth, J; Pocard, M; Rymer, R; Soyer, P	1
Carney, JA; Chapman, AD; Dempsey, OJ; Gomersall, LN; Sawhney, SA	1
Fujiwara, H; Ichikawa, D; Ikoma, H; Kikuchi, S; Kokuba, Y; Kubota, T; Nakanishi, M; Ochiai, T; Okamoto, K; Otsuji, E; Sakakura, C; Sonoyama, T; Taniguchi, H	1
Endo, S; Hosoya, Y; Kurashina, K; Lefor, A; Sakurai, S; Yasuda, Y	1
Chang, I; Choi, D; Kim, KM; Lee, JY; Lee, WJ; Sohn, TS; Yoo, EY	1
Blanpain, S; Brasseur, A; Brochart, C; Chatelain, D; Demuynck, F; Fuks, D; Morvan, J; Robert, B; Yzet, T	1
Ahrar, K; Ensor, J; Gupta, S; Hicks, ME; Kobayashi, K; Madoff, DC; Murthy, R; Szklaruk, J; Trent, JC; Wallace, MJ	1
Kurtaran, A; Schima, W	1
Baba, N; Ishigami, S; Kitaguchi, K; Nakayama, Y; Ooe, H; Taira, K; Tamura, J; Ura, K; Yoshikawa, A	1
Oka, M; Sakamoto, K; Tsutsui, M; Yoshino, S	1
Ebihara, T; Ishida, Y; Kondo, S; Matsuda, R; Minami, T; Sato, S; Tanaka, T; Togo, G; Watanabe, Y; Yamada, A; Yamazaki, K; Yotsuya, S	1
Hou, M; Jiang, M; Yang, Y; Zhou, L; Zhu, J	1
Benekli, M; Bilge Yilmaz, I; Buyukberber, S; Coskun, U; Demirci, U; Erdem, O; Ozturk, B	1
Ji, L; Li, X; Wu, XT; Xia, L; Zhang, MM	1
Bauer, S; Grabellus, F; Schmid, KW; Sheu, SY; Speich, N; Worm, K	1
Berger, F; Bruns, C; Reichardt, P; Schinwald, N; Schlemmer, M	1
Broelsch, CE; Frilling, A; Grabellus, F; Kronenberger, R; Li, J; Malago, M; Schleyer, E; Testa, G	1
Hirota, S; Hori, K; Kim, Y; Matsumoto, T; Miwa, H; Oh, K; Oshima, T; Tanaka, J; Tomita, T; Watari, J	1
Hamazoe, R; Hisamitsu, K; Kimura, O; Yamamoto, O; Yamane, N	1
Cheung, WY; Ksienski, D	1
Kamiya, K; Kikuchi, H; Konno, H; Miyazaki, S; Ohta, M; Sakaguchi, T; Setoguchi, T; Yamamoto, M	1
Onoe, S; Sakamoto, Y	1
Akimoto, H; Chinen, Y; Kawano, H; Kojo, M; Minami, K; Morita, K; Okamura, T; Saeki, H; Sakaguchi, Y; Sakamoto, Y; Soejima, Y; Sugiyama, M; Toh, Y	1
Andrich, K; Dalhoff, C; Dreger, M; Fischer, JJ; Glinski, M; Graebner, OY; Koester, H; Kroll, F; Michaelis, S; Schrey, AK; Sefkow, M	1
Cervera, P; Fléjou, JF	1
Ando, K; Kakeji, Y; Kojima, A; Maehara, Y; Morita, M; Oki, E; Saeki, H; Sugiyama, M; Taketomi, A; Tsujitani, S; Yamamoto, H; Yamashita, Y; Zhao, Y	1
Antonescu, C	1
Adenis, A; Antonescu, CR; Blay, JY; Bompas, E; Bui, B; Casali, P; Cioffi, A; Coco, P; Coindre, JM; Debiec-Rychter, M; Duffaud, F; Isambert, N; Italiano, A; Keohan, ML; Le Cesne, A; Maki, RG; Rutkowski, P; Schöffski, P; Toulmonde, M	1
Liang, J; Liu, ZM; Yu, Z	1
Goto, K; Ishikawa, O; Kishi, K; Kittaka, H; Miyashiro, I; Motoori, M; Noura, S; Ogawa, H; Ohigashi, H; Ohue, M; Shingai, T; Takahashi, H; Yamada, T; Yano, M	1
Caltabiano, G; Queirolo, P; Spagnolo, F	1
George, S; Hornick, JL; Jagannathan, JP; Ramaiya, NH; Shinagare, AB	1
Mourad, F; Saad Aldin, E; Tfayli, A	1
Inoue, M; Itoh, G; Matsuzaki, T; Ogawa, M; Osaka, H; Yamamoto, T	1
Alaggio, R; Bisogno, G; Cecchetto, G; Cheng, L; d'Amore, ES; Dall'Igna, P; Martignoni, G; Sperlì, D	1
Hamasu, S; Jinzai, Y; Kanto, S; Kobayashi, A; Konishi, S; Manaka, D; Nishitai, R; Sakamoto, K; Uehara, M; Yasuhara, Y; Yokoyama, D; Yoshino, K	1
Chayama, K; Higashi, Y; Kitadai, Y; Ohara, E; Ohnishi, M; Onoyama, M; Shinagawa, K; Sumida, T; Tanaka, M; Tanaka, S; Yasui, W	1
De Giorgi, U; de Jong, FA; Eechoute, K; Fransson, MN; Friberg, LE; Loos, WJ; Mathijssen, RH; Reyners, AK; Schiavon, G; Sparreboom, A; van der Graaf, WT; Verweij, J; Wiemer, EA	1
Judson, I	1
Baba, M; Hara, Y; Hayashi, T; Honda, M; Ikeda, H; Kaneko, S; Kondo, M; Mizukoshi, E; Nakamoto, Y; Nio, K; Takamura, H; Takatori, H; Wang, XW; Yamashita, T; Zen, Y; Zeng, SS	1
Agarwal, N; Bhaskaran, S; Goel, N; Malik, R; Mehta, S; Rajaram, S; Rathi, B	1
Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Minato, H; Morioka, E; Nakano, Y; Nakata, S; Noguchi, M; Ohnishi, T; Ohno, Y; Omote, K; Takamura, H; Tomita, Y; Ueda, N	1
Campbell, SC; Hantel, A; Kash, J; Paner, GP; Sakamoto, K; Voelzke, BB; Waters, WB	1
DeMatteo, RP	1
Antonescu, C; Brennan, MF; Dematteo, RP; Maki, RG	1
De Arriba, JJ; García, E; Gómez-Aldaraví, L; Nerín, C; Vila, B	1
Chmelik, P; Felix, R; Gaffke, G; Hohenberger, P; Jost, D; Pink, D; Reichardt, P; Schlecht, I; Schneider, U; Stroszczynski, C	1
Doi, T; Funada, N; Matsumoto, G; Okamoto, A; Sasaki, K; Tsuruta, K	1
Lilien, DL; Reddy, MP; Reddy, P	1
Hara, K; Inada, K; Matsuura, A; Nakamura, T; Ohashi, K; Ohno, R; Okubo, K; Sawaki, A; Shimizu, Y; Suzuki, T; Yamao, K	1
Godény, M; Hitre, E; Horváth, Z; Láng, I	1
Catania, C; Curigliano, G; Danesi, R; De Braud, F; De Pas, T	1
Hirohashi, K; Kanazawa, A; Kinoshita, H; Kubo, S; Shuto, T; Takemura, S; Tanaka, H; Yamamoto, S; Yamamoto, T	1
Besznyák, I; Bodoky, G; Eckhardt, S; Esik, O; Gödény, M; Horti, J; Jakab, K; Nagy, T; Orosz, Z; Pápai, Z; Sápi, Z; Tamás, K; Trón, L	1
Dudek, K; Grzesiakowska, U; Krawczyk, M; Nasierowska-Guttmejer, A; Nowecki, ZI; Nyckowski, P; Pienkowski, A; Ruka, W; Rutkowski, P	1
Imai, K; Yoshida, Y	1
Arakawa, Y; Fuchigami, M; Ito, T; Kobayashi, S; Koide, H; Murata, A; Nishiyama, R; Sagawa, C; Takekawa, Y	1
Brink, I; Dirnhofer, S; Hartmann, M; Jakob, A; Marx, A; Mikesch, K; Ströbel, P	1
Durham, MM; Gow, KW; Katzenstein, HM; Lorenzo, RL; Ricketts, RR; Shehata, BM	1
Juan, MB; López-Andújar, R; Mir, JP; Moya, AH; Orbis, FC; Pareja, EI; Rayón, M; Sanjuan, FR; Serralta, AS; Vila, JC	1
Baba, M; Hiramatsu, Y; Kamiya, K; Kanda, T; Kikuchi, H; Kondo, K; Konn, H; Nakamura, S; Ohashi, M; Ohta, M; Sugimura, H; Tanaka, T; Yamamoto, M	1
Higuchi, T; Matsumoto, T; Tate, G; Yamaguchi, M	1
Aoki, R; Imoto, Y; Ito, S; Muguruma, N; Nakamoto, J; Okamoto, K; Okamura, S; Okitsu, H; Sano, T; Sato, Y	1
Ando, Y; Beck, Y; Tahara, H; Takayama, T; Tsunoda, T	1
Blyweert, W; De Ridder, D; Debiec-Rychter, M; Ost, D; Sciot, R; Van der Aa, F; Van Oosterom, A; Van Poppel, H	1
Goto, T; Igaki, N; Kanda, S; Matsuda, T; Ohyama, M; Takashima, M; Tamada, F	1
Akisik, FM; Henley, JD; Rajesh, A; Rushing, DA; Rydberg, J; Sandrasegaran, K	1
Armbrust, T; Füzesi, L; Gunawan, B; Langer, C; Ramadori, G; Schindler, CG	1
Jin, ML; Shen, L	1
Albiter, M; Bonvalot, S; Caillet, H; Dromain, C; Le Cesne, A; Le Pechoux, C; Petrow, P; Shapeero, L; Terrier, P; Vanel, D	1
Bonginelli, P; Carillio, G; Gasparini, G; Longo, R; Morabito, A; Vitale, S	1
Briasoulis, E; Karavasilis, V; Marselos, M; Pappas, P; Pavlidis, N	1
Chen, J; Ebert, MP; Gschaidmeier, H; Hosius, C; Kahl, S; Malfertheiner, P; Nitsche, B; Röcken, C	1
She, R; Szakacs, J	1
Ausania, F; Caricato, M; Coppola, R; Rabitti, C; Tonini, G; Valeri, S	1
Aliberti, C; Benea, G; Conti, M; De Giorgi, U; Marangolo, M	1
Apice, G; Botti, G; De Chiara, A; De Rosa, V; Franco, R; Iaffaioli, VR; Lastoria, S	1
Bauer, S; Hartmann, JT; Lang, H; Schütte, J	1
Hayashi, Y; Kajiyama, Y; Miyano, T; Okazaki, T; Tsurumaru, M; Yamashiro, Y; Yamataka, A; Yanai, T	1
Fukuda, K; Hagiwara, A; Kin, S; Kuriu, Y; Miyagawa, K; Nakase, Y; Nakashima, S; Sagara, Y; Sakakura, C; Yamagishi, H; Yamaoka, N; Yoshikawa, T	1
Belhorn, T; Blatt, J; Fordham, LA; McDonald, M; McLean, T; Smith, SV; Woods, C	1
Dobritz, M; Eckel, F; Fend, F; Hosius, C; Lersch, C; Mayr, M; Schleyer, E; Schmid, RM; Schulte-Frohlinde, E; von Delius, S	1
Melichar, B; Michal, M; Nozicka, J; Ryska, A; Urminská, H; Vanecek, T; Voboril, Z	1
Liu, YK; Qin, LX; Sun, HC; Tang, ZY; Wang, L; Wu, WZ; Xu, Y; Ye, SL; Zhang, KZ; Zhang, T	1
Baba, M; Hiramatsu, Y; Kamiya, K; Kawabata, T; Kikuchi, H; Kitagawa, K; Kitagawa, M; Kondo, K; Konno, H; Ohta, M; Sugimura, H; Suzuki, S; Tanaka, T; Yamamoto, M; Yamashita, K	1
Hagiwara, A; Kin, S; Miyagawa, K; Nakase, Y; Nakashima, S; Sagara, Y; Sakakura, C; Soga, K; Yamagishi, H; Yamaoka, N; Yoshikawa, T	1
Bernardeschi, P; Biancalani, M; De Simone, M; Dentico, P; Fiorentini, G; Palomba, A; Rossi, S; Scuderi, S; Vaira, M	1
Azuma, M; Higuchi, K; Katada, C; Koizumi, W; Nakatani, K; Nishimura, K; Saigenji, K; Sasaki, T; Shimoda, T; Tanabe, S	1
Linton, KM; Radford, JA; Taylor, MB	1
Brody, LA; Brown, KT; Covey, AM; DeMatteo, R; Getrajdman, GI; Maluccio, MA; Schubert, J; Sofocleous, CT	1
Bonvalot, S; Cavalcanti, A; Cesne, AL; Eldweny, H; Lassau, N; Péchoux, CL; Robert, C; Terrier, P; Vanel, D	1
Al-Kindy, S; Al-Moundhri, MS; Al-Thahli, K; Rao, L; Salam, J	1
Joensuu, H	1
Bonvalot, S; Chami, L; Lamuraglia, M; Lassau, N; Le Cesne, A; Leclère, J; Roche, A; Terrier, P	1
Biolchini, F; Jovine, E; Lerro, FM; Martuzzi, F; Mastrangelo, L	1
Hirai, S; Ishikawa, A; Kakinoki, N; Kamoshida, T; Kishimoto, Y; Ochiai, T; Oka, Y; Ono, S; Shimokama, T; Teratani, T	1
Brilloff, S; Broering, DC; Goumas, FA; Himpel, S; Mueller, L; Rogiers, X	1
Ikeda, E; Sakurai, N; Sasou, S; Shibuma, H; Yamauchi, J	1
Allgaier, HP; Becker, G; Blum, HE; Ertelt, V; Schmitt-Graeff, A	1
Ishiwata, T; Kanazawa, Y; Koizumi, M; Naito, Z; Nakazawa, N; Ohaki, Y; Seya, T; Shinji, S; Tajiri, T; Takahashi, Y; Tanaka, N; Teranishi, N; Yamada, T; Yokoi, K	1
Gatopoulou, A; Katodritou, E; Katsos, I; Patakiouta, F; Tarpagos, A; Tzilves, D; Zervas, K	1
Darwiche, SS; El-Kinge, N; Jamali, FR; Soweid, AM; Tawil, A	1
Hiki, N; Imamura, K; Kaminishi, M; Katayama, A; Kubota, K; Mafune, K; Nomura, S; Nozaki, K; Takeshita, Y; Ueda, T	1
Azim, HA; Elsedewy, E	1
Akmansu, M; Atik, ET; Boruban, C; Ozbek, S; Sencan, O	1
Al Bahar, S; Pandita, R; Prakash, A; Ramamoorthy, SK; Ramaswamy, NV	1
Berneburg, M; Bitzer, M; Metzler, G; Müller-Hermelink, HK; Röcken, M; Weyrauch, S; Yazdi, AS	1
Alpers, CE; Bauer, RL; Campbell, JS; Fausto, N; Gilbertson, DG; Hudkins, KL; Johnson, MM; Riehle, KJ; Yeh, MM	1
Date, RS; Mughal, MM	1
Hosius, C; Malfertheiner, P; Schleyer, E; Treiber, G; Troeger, U; Wex, T	1
Astorino, M; Biasco, G; Brandi, G; Castellucci, P; Catena, F; Di Battista, M; Di Scioscio, V; Pantaleo, MA; Piazzi, G; Santini, D; Saponara, M	1
Fisher, GA; Levitt, L; Lin, AY; So, S; Tang, C	1
Ghersi, MM; Mesko, TW; Paramo, JC; Radkani, P	1
Hou, M; Li, HY; Wang, Y; Zhang, J; Zhu, J	1
Andersson, LC; Capdeville, R; Demetri, GD; Dimitrijevic, S; Druker, B; Joensuu, H; Roberts, PJ; Sarlomo-Rikala, M; Silberman, S; Tervahartiala, P; Tuveson, D	1
Abe, K; Kato, K; Maekawa, T; Saito, K; Sato, K; Takeda, Y; Terashima, M; Uesugi, N	1

Reviews

18 review(s) available for imatinib mesylate and Liver Neoplasms

Article	Year
Unresectable GIST liver metastases and liver transplantation: A review and theoretical basis for a new indication. International journal of surgery (London, England), 2021, Volume: 94 Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Liver Transplantation; Prospective Studies	2021
The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1 Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus	2016
A Rare Case of a Metastatic Gastrointestinal Stromal Tumor (GIST): a Case Report and Review of the Literature. Journal of gastrointestinal cancer, 2019, Volume: 50, Issue:4 Topics: Biopsy; Cervical Vertebrae; Colonoscopy; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Rectum; Spinal Neoplasms; Tomography, X-Ray Computed	2019
Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment? Current cancer drug targets, 2019, Volume: 19, Issue:1 Topics: Antimetabolites; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Deoxyglucose; Flavonoids; Glucose Transporter Type 1; Glycolysis; Humans; Imatinib Mesylate; Liver Neoplasms; Protein Kinase Inhibitors	2019
[Two cases of primary unresectable and/or recurrent gastrointestinal stromal tumors of small intestine presenting hemoperitoneum caused by administration of imatinib mesylate]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2008, Volume: 105, Issue:11 Topics: Aged; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Digestive System Surgical Procedures; Emergencies; Fatal Outcome; Gastrointestinal Stromal Tumors; Hemoperitoneum; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Treatment Outcome	2008
Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature. Journal of cutaneous pathology, 2009, Volume: 36, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Bone Neoplasms; Carcinoma; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Indoles; Liver Neoplasms; Piperazines; Pyrimidines; Pyrroles; Soft Tissue Neoplasms; Subcutaneous Fat; Sunitinib	2009
Liver transplantation for metastasized extragastrointestinal stromal tumor: a case report and an overview of literature. Transplantation proceedings, 2010, Volume: 42, Issue:9 Topics: Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Living Donors; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Rectal Neoplasms; Time Factors; Treatment Outcome; Vaginal Neoplasms	2010
Changing pathology with changing drugs: tumors of the gastrointestinal tract. Pathobiology : journal of immunopathology, molecular and cellular biology, 2011, Volume: 78, Issue:2 Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Liver Neoplasms; Molecular Targeted Therapy; Mutation; Neoplasm Staging; Pancreatic Neoplasms; Pathology, Molecular; Piperazines; Precision Medicine; Pyrimidines; Signal Transduction; Trastuzumab	2011
Gastrointestinal stromal tumors. Current topics in microbiology and immunology, 2012, Volume: 355 Topics: Antineoplastic Agents; Benzamides; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Activation; Exons; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Molecular Targeted Therapy; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Sunitinib	2012
Uveal melanoma. Cancer treatment reviews, 2012, Volume: 38, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bevacizumab; Chemotherapy, Adjuvant; Humans; Imatinib Mesylate; Immunotherapy; Ipilimumab; Liver Neoplasms; Melanoma; Piperazines; Pyrimidines; Uveal Neoplasms	2012
Gastric antral vascular ectasia in a patient with GIST after treatment with imatinib: case report and literature review. Japanese journal of clinical oncology, 2012, Volume: 42, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Endoscopy, Digestive System; Female; Gastric Antral Vascular Ectasia; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines	2012
Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature. Journal of pediatric surgery, 2012, Volume: 47, Issue:6 Topics: Abdominal Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Child, Preschool; Combined Modality Therapy; Diagnostic Errors; Etoposide; Female; Humans; Imatinib Mesylate; Intestinal Obstruction; Ligaments; Liver Neoplasms; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Perivascular Epithelioid Cell Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radiography; Sarcoma, Clear Cell; Sirolimus; X Chromosome Inactivation	2012
Gastrointestinal stromal tumor: involvement in urologic patients and recent therapeutic advances. Urology, 2002, Volume: 60, Issue:2 Topics: Antigens, Neoplasm; Antineoplastic Agents; Benzamides; Carcinoma, Renal Cell; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Piperazines; Prostatic Neoplasms; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma	2002
The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571). Annals of surgical oncology, 2002, Volume: 9, Issue:9 Topics: Antineoplastic Agents; Benzamides; Embolization, Therapeutic; Enzyme Inhibitors; Gastrointestinal Neoplasms; Hepatic Artery; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Mutation; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrimidines	2002
Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumor. Current problems in surgery, 2003, Volume: 40, Issue:3 Topics: Benzamides; Biopsy, Needle; Chemotherapy, Cancer, Regional Perfusion; Enzyme Inhibitors; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Neoplasm Staging; Peritoneal Neoplasms; Piperazines; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Stromal Cells; Survival Analysis; Treatment Outcome	2003
[Tailored therapy in gastrointestinal and hepatic cancer--toward ideal medicine through genomic science]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2004, Volume: 101, Issue:3 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bevacizumab; Drug Design; Drug Resistance, Neoplasm; Enzymes; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Targeting; Genetic Therapy; Genomics; Humans; Imatinib Mesylate; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Pyrimidines; Vascular Endothelial Growth Factor A	2004
Gastrointestinal stromal tumor in a child and review of the literature. Pediatric surgery international, 2005, Volume: 21, Issue:11 Topics: Adolescent; Benzamides; Bromhexine; Chemotherapy, Adjuvant; Endoscopy, Gastrointestinal; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2005
Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature. Onkologie, 2007, Volume: 30, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Cisplatin; Dendritic Cells, Follicular; Deoxycytidine; Follow-Up Studies; Gemcitabine; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome	2007

Trials

12 trial(s) available for imatinib mesylate and Liver Neoplasms

Article	Year
The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1 Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus	2016
Surgery and imatinib therapy for liver oligometastasis of GIST: a study of Japanese Study Group on GIST. Japanese journal of clinical oncology, 2017, Apr-01, Volume: 47, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Japan; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Salvage Therapy	2017
Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!). European journal of radiology, 2009, Volume: 69, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2009
Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors. Surgery today, 2010, Volume: 40, Issue:10 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Retrospective Studies; Treatment Outcome	2010
[Morphology of gastrointestinal stromal tumors in advanced stages of the disease: baseline findings before chemotherapy with imatinib]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2003, Volume: 175, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Benzamides; Chemotherapy, Adjuvant; Contrast Media; Digestive System; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Image Enhancement; Imatinib Mesylate; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Mesothelial; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Tomography, X-Ray Computed	2003
[Effect of imatinib treatment of gastrointestinal stromal tumors]. Orvosi hetilap, 2003, Nov-09, Volume: 144, Issue:45 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Drug Administration Schedule; Enzyme Inhibitors; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines; Remission Induction; Stromal Cells; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome	2003
Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib. Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Chromosome Aberrations; DNA, Neoplasm; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nucleic Acid Hybridization; Piperazines; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Risk Factors; Safety; Time Factors; Tomography, X-Ray Computed	2005
The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression. Cancer letters, 2006, Feb-28, Volume: 233, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Benzamides; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Quality of Life; Receptors, Platelet-Derived Growth Factor; Surveys and Questionnaires; Survival Rate	2006
Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma. Oncology, 2005, Volume: 69, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Cohort Studies; Disease-Free Survival; Enzyme Inhibitors; Fibrosis; Humans; Imatinib Mesylate; Immunohistochemistry; Liver; Liver Neoplasms; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Stem Cells; Time Factors; Treatment Outcome	2005
Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. AJR. American journal of roentgenology, 2006, Volume: 187, Issue:5 Topics: Antineoplastic Agents; Benzamides; Contrast Media; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Phospholipids; Piperazines; Polysaccharides; Prognosis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Sulfur Hexafluoride; Ultrasonography, Doppler	2006
Imatinib for hepatocellular cancer--focus on pharmacokinetic/pharmacodynamic modelling and liver function. Cancer letters, 2008, Feb-18, Volume: 260, Issue:1-2 Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Becaplermin; Benzamides; Carcinoma, Hepatocellular; Female; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Male; Middle Aged; Models, Biological; Octreotide; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pyrimidines; Vascular Endothelial Growth Factor A	2008
Phase II study of imatinib in unresectable hepatocellular carcinoma. American journal of clinical oncology, 2008, Volume: 31, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Heart Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Piperazines; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Survival Rate; Treatment Outcome	2008

Other Studies

192 other study(ies) available for imatinib mesylate and Liver Neoplasms

Article	Year
[A Case of Hepatocellular Carcinoma with Extrahepatic Growth-A Difficult Preoperative Diagnosis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2021, Volume: 48, Issue:13 Topics: Aged; Carcinoma, Hepatocellular; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Stomach Neoplasms	2021
[A Case of HER2-Positive Recurrent Breast Cancer and Liver Metastases of GIST Treated with Combined Anti-HER2 Therapy and Imatinib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2021, Volume: 48, Issue:13 Topics: Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms	2021
FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumor. Genes, chromosomes & cancer, 2022, Volume: 61, Issue:7 Topics: Antineoplastic Agents; Carrier Proteins; Gastrointestinal Stromal Tumors; Gene Fusion; Humans; Imatinib Mesylate; Liver Neoplasms; Mutation; Proto-Oncogene Proteins c-kit; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Platelet-Derived Growth Factor alpha; Tumor Suppressor Proteins	2022
[A Case of Long-Term Survival after Multimodal Therapy against Gastric GIST with Multiple Hepatic Metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:2 Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Stomach Neoplasms	2022
Assessment of hyaluronic acid-modified imatinib mesylate cubosomes through CD44 targeted drug delivery in NDEA-induced hepatic carcinoma. International journal of pharmaceutics, 2022, Jun-25, Volume: 622 Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; Humans; Hyaluronan Receptors; Hyaluronic Acid; Imatinib Mesylate; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tissue Distribution	2022
Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma. Frontiers in immunology, 2022, Volume: 13 Topics: Apoptosis; Carcinoma, Hepatocellular; Copper; CTLA-4 Antigen; DNA Copy Number Variations; Humans; Imatinib Mesylate; Liver Neoplasms; Methotrexate; Prognosis; Sorafenib; Tumor Microenvironment	2022
Urgent Surgical Treatment of GIST of Esophago-Gastric Junction in a Patient with Giant Hiatal Hernia. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2019,Summer, Volume: 32, Issue:4 Topics: Aged; Anastomosis, Surgical; Antineoplastic Agents; Esophageal Neoplasms; Esophagogastric Junction; Female; Gastrectomy; Gastrointestinal Stromal Tumors; Hernia, Hiatal; Humans; Imatinib Mesylate; Intraoperative Complications; Liver Neoplasms	2019
Long-Term Survival After Multidisciplinary Treatment Including Surgery for Metachronous Metastases of Small Intestinal Gastrointestinal Stromal Tumors after Curative Resection: A Case Report. The American journal of case reports, 2019, Dec-26, Volume: 20 Topics: Bone Neoplasms; Combined Modality Therapy; Fatal Outcome; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leiomyosarcoma; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Sunitinib	2019
[A Case of Gastrointestinal Stromal Tumor Re-Resected Ten Years after the Resection of Its Recurrence]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:13 Topics: Aged; Angiomyolipoma; Antineoplastic Agents; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Neoplasm Recurrence, Local	2019
Living Donor Liver Transplantation for Imatinib-Resistant Gastrointestinal Stromal Tumor Liver Metastases: A New Therapeutic Option in Transplant Oncology. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2020, Volume: 26, Issue:7 Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Liver Transplantation; Living Donors	2020
Primary Hepatic Gastrointestinal Stromal Tumour (GIST): Unusual Presentation and Diagnosis. Journal of gastrointestinal cancer, 2020, Volume: 51, Issue:3 Topics: Aged; Anorexia; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Weight Loss	2020
Establishment of a Patient-Derived Xenograft Tumor From Hepatitis C-Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy. Hepatology (Baltimore, Md.), 2020, Volume: 72, Issue:2 Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Hepatitis C, Chronic; Heterografts; Humans; Imatinib Mesylate; Liver Neoplasms; Mice; Neoplasm Transplantation; Treatment Outcome; Xenograft Model Antitumor Assays	2020
[Case of Intestinal GIST with Long-Term Survival after Multidisciplinary Treatment, Including Surgical Resection for Liver Metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:1 Topics: Combined Modality Therapy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged	2020
[Case of Peritoneal Dissemination from Gastrointestinal Stromal Tumor of Jejunum Treated with Repeated Non-Curative Surgery]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:1 Topics: Aged; Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Jejunum; Liver Neoplasms; Male	2020
Living Donor Liver Transplantation for Imatinib-Resistant Gastrointestinal Stromal Tumor Liver Metastases: A New Therapeutic Option in Transplant Oncology. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2020, Volume: 26, Issue:10 Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Liver Transplantation; Living Donors; Transplants	2020
Combined Partial Gastrectomy, Splenectomy, and Microwave Liver Ablation of Metastatic Gastrointestinal Stromal Tumor After 4 Years of Neoadjuvant Imatinib. The American surgeon, 2020, Volume: 86, Issue:5 Topics: Antineoplastic Agents; Cholecystectomy; Female; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Lymph Node Excision; Microwaves; Middle Aged; Neoadjuvant Therapy; Splenectomy	2020
Reply. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2020, Volume: 26, Issue:10 Topics: Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Liver Transplantation; Living Donors; Transplants	2020
[A case of gastrointestinal stromal tumor of the duodenum with ruptured liver metastasis during administration of imatinib]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2020, Volume: 117, Issue:10 Topics: Duodenum; Embolization, Therapeutic; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged	2020
Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFκB, BCR/ABL, and PI3K/AKT signaling pathway-related proteins. FEBS open bio, 2021, Volume: 11, Issue:3 Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Imatinib Mesylate; Liver Neoplasms; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfasalazine	2021
Fabrication of Imatinib Mesylate-Loaded Lactoferrin-Modified PEGylated Liquid Crystalline Nanoparticles for Mitochondrial-Dependent Apoptosis in Hepatocellular Carcinoma. Molecular pharmaceutics, 2021, 03-01, Volume: 18, Issue:3 Topics: Animals; Apoptosis; Biological Availability; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Imatinib Mesylate; Lactoferrin; Liquid Crystals; Liver Neoplasms; Male; Mitochondria; Nanoparticles; Particle Size; Polyethylene Glycols; Rats; Rats, Wistar; Tissue Distribution	2021
Imatinib and nutritional support can make successful treatment for a case of huge liver metastasis of duodenal gastrointestinal stromal tumor that initially showed jaundice and cachexia. Clinical journal of gastroenterology, 2021, Volume: 14, Issue:2 Topics: Adult; Antineoplastic Agents; Cachexia; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jaundice; Liver Neoplasms; Neoplasm Recurrence, Local; Nutritional Support	2021
LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis. Anti-cancer drugs, 2021, 04-01, Volume: 32, Issue:4 Topics: Case-Control Studies; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Neoplasms; Male; MicroRNAs; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; RNA, Long Noncoding; Signal Transduction; Up-Regulation	2021
[A Case on the Long‒Term Effect of Imatinib on GIST of Unknown Primary Origin with Multiple Liver Metastases, Peritoneal Dissemination, and Bone Metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2021, Volume: 48, Issue:4 Topics: Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Neoplasms, Unknown Primary	2021
Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy. European journal of pharmacology, 2021, Sep-05, Volume: 906 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Mice; Neoplasm Invasiveness; Sorafenib; Xenograft Model Antitumor Assays	2021
A liver metastasis 7 years after resection of a low-risk duodenal gastrointestinal stromal tumor. Clinical journal of gastroenterology, 2021, Volume: 14, Issue:5 Topics: Duodenal Neoplasms; Duodenum; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged	2021
Humeral metastasis as the only recurrence of a 5-year resected gastrointestinal stromal tumor: a case report. Journal of medical case reports, 2021, Aug-18, Volume: 15, Issue:1 Topics: Aged; Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Humans; Humerus; Imatinib Mesylate; Liver Neoplasms; Neoplasm Recurrence, Local	2021
Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib-Treated Patients With Gastrointestinal Stromal Tumors. CPT: pharmacometrics & systems pharmacology, 2017, Volume: 6, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Models, Biological; Protein Kinase Inhibitors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden	2017
An Unusual Liver Tumor. Gastroenterology, 2017, Volume: 153, Issue:4 Topics: Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Tomography, X-Ray Computed; Treatment Outcome	2017
Abdominal Ultrasound – The Leading Method in Duodenal Gist Diagnostics Acta clinica Croatica, 2017, Volume: 56, Issue:1 Topics: Adult; Antineoplastic Agents; Digestive System Surgical Procedures; Duodenal Neoplasms; Endoscopy, Digestive System; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Magnetic Resonance Spectroscopy; Maintenance Chemotherapy; Metastasectomy; Tomography, X-Ray Computed; Ultrasonography	2017
Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China. Medicine, 2017, Volume: 96, Issue:46 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; China; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Protein-Tyrosine Kinases; Retrospective Studies; Young Adult	2017
Advanced gastrointestinal stromal tumor patients benefit from palliative surgery after tyrosine kinase inhibitors therapy. Medicine, 2018, Volume: 97, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Palliative Care; Peritoneal Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Retrospective Studies; Treatment Outcome	2018
Adverse reactions of sorafenib, sunitinib, and imatinib in treating digestive system tumors. Thoracic cancer, 2018, Volume: 9, Issue:5 Topics: Adult; Aged; Carcinoma, Hepatocellular; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Stromal Tumors; Humans; Hypertension; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Sorafenib; Sunitinib	2018
ATP-based cell viability assay is superior to trypan blue exclusion and XTT assay in measuring cytotoxicity of anticancer drugs Taxol and Imatinib, and proteasome inhibitor MG-132 on human hepatoma cell line HepG2. Clinical hemorheology and microcirculation, 2018, Volume: 69, Issue:1-2 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biological Assay; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Humans; Imatinib Mesylate; Liver Neoplasms; Paclitaxel; Proteasome Inhibitors; Trypan Blue	2018
Primary Gastrointestinal Stromal Tumor of the Liver. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:9 Topics: Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Tomography, X-Ray Computed	2019
Possible modulation of concurrent Parkinson's disease in the management of metastatic GIST: a review of two cases. The journal of the Royal College of Physicians of Edinburgh, 2018, Volume: 48, Issue:3 Topics: Aged; Antineoplastic Agents; Antiparkinson Agents; Carbidopa; Drug Combinations; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Levodopa; Liver Neoplasms; Male; Parkinson Disease; Severity of Illness Index; Stomach Neoplasms	2018
Successful treatment of metastatic mucosal melanoma with a Del579 c-KIT mutation by imatinib after treatment of anti-PD-1 antibody. Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:3 Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Base Sequence; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Lymphatic Metastasis; Melanoma; Mucous Membrane; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins c-kit; Sequence Deletion; Vulvar Neoplasms	2019
Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China. Clinics and research in hepatology and gastroenterology, 2019, Volume: 43, Issue:3 Topics: Adult; Aged; China; Combined Modality Therapy; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Length of Stay; Liver Neoplasms; Male; Middle Aged; Postoperative Complications; Prognosis; Protein Kinase Inhibitors; Radiofrequency Ablation; Retrospective Studies; Sunitinib	2019
[A Case of Rectal Gastrointestinal Stromal Tumor(GIST)with Long-Term Survival Treated with Multidisciplinary Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13 Topics: Aged; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Pyrimidines	2018
TGF-β1 elevates P-gp and BCRP in hepatocellular carcinoma through HOTAIR/miR-145 axis. Biopharmaceutics & drug disposition, 2019, Volume: 40, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Base Sequence; Biological Transport; Carcinoma, Hepatocellular; CHO Cells; Cricetulus; Drug Resistance, Neoplasm; Female; HCT116 Cells; Hep G2 Cells; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Mice; Mice, Knockout; MicroRNAs; Neoplasm Proteins; RNA, Long Noncoding; Transforming Growth Factor beta1	2019
[Hepatic and Pancreatic Metastases of a Rectal Gastrointestinal Stromal Tumor in a Patient with Long-Term Survival following Combined Therapy-ACase Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:2 Topics: Aged; Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Neoplasm Recurrence, Local; Pancreatic Neoplasms	2019
Copper Mediates Anti-Inflammatory and Antifibrotic Activity of Gleevec in Hepatocellular Carcinoma-Induced Male Rats. Canadian journal of gastroenterology & hepatology, 2019, Volume: 2019 Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Chelating Agents; Copper; Cytokines; Disulfiram; Imatinib Mesylate; Inflammation; Inflammation Mediators; Liver Neoplasms; Male; Rats; Rats, Wistar	2019
Rectal stromal tumor with an exceptional liver and bone metastatic locations. The Pan African medical journal, 2019, Volume: 32 Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Rectal Neoplasms; Tomography, X-Ray Computed	2019
Quantitative Mass Spectrometry Imaging Reveals Mutation Status-independent Lack of Imatinib in Liver Metastases of Gastrointestinal Stromal Tumors. Scientific reports, 2019, 07-23, Volume: 9, Issue:1 Topics: Antineoplastic Agents; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Mutation; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2019
Osteonecrosis of the tibia associated with imatinib in metastatic GI stromal tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jun-01, Volume: 31, Issue:16 Topics: Antineoplastic Agents; Benzamides; Disease Progression; Drug Administration Schedule; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Incidental Findings; Liver Neoplasms; Middle Aged; Osteonecrosis; Pain; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Range of Motion, Articular; Tibia	2013
A role for adjuvant RFA in managing hepatic metastases from gastrointestinal stromal tumors (GIST) after treatment with targeted systemic therapy using kinase inhibitors. Cardiovascular and interventional radiology, 2014, Volume: 37, Issue:1 Topics: Adult; Aged; Benzamides; Catheter Ablation; Combined Modality Therapy; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radio Waves; Retrospective Studies; Survival Rate	2014
Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate. Vojnosanitetski pregled, 2013, Volume: 70, Issue:2 Topics: Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Piperazines; Pyrimidines; Stomach Neoplasms	2013
[Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 2013, Volume: 42, Issue:1 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Exons; Gastrectomy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Pyrimidines	2013
Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour. ANZ journal of surgery, 2014, Volume: 84, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Piperazines; Pyrimidines; Retrospective Studies; Survival Analysis; Treatment Outcome	2014
Primary GIST of the liver masquerading as primary intra-abdominal tumour: a rare extra-gastrointestinal stromal tumour (EGIST) of the liver. Journal of gastrointestinal cancer, 2014, Volume: 45, Issue:3 Topics: Abdominal Neoplasms; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Diagnostic Errors; Diagnostic Imaging; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Multimodal Imaging; Piperazines; Positron-Emission Tomography; Pyrimidines; Tomography, X-Ray Computed	2014
[A case of liver and bone metastases after complete resection of gastric GIST effectively treated with radiotherapy and imatinib mesylate]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2013, Volume: 110, Issue:7 Topics: Aged; Antineoplastic Agents; Benzamides; Bone Neoplasms; Combined Modality Therapy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Pyrimidines	2013
[Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:6 Topics: Abdominal Neoplasms; Abdominal Wall; Aged, 80 and over; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Piperazines; Pyrimidines; Recurrence; Stomach Neoplasms; Tomography, X-Ray Computed	2013
Imatinib plasma monitoring-guided dose modification for managing imatinib-related toxicities in gastrointestinal stromal tumor patients. Journal of Korean medical science, 2013, Volume: 28, Issue:8 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Monitoring; Exons; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Mutation; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Tomography, X-Ray Computed	2013
The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST. Annals of surgical oncology, 2013, Volume: 20, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Digestive System Surgical Procedures; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Retrospective Studies; Survival Rate	2013
[A rare case of bone metastasis from gastro-intestinal stromal tumour: place of radiotherapy]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:1 Topics: Antineoplastic Agents; Benzamides; Bone Neoplasms; Femoral Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Humerus; Imatinib Mesylate; Ischium; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Osteolysis; Pain Management; Peritoneal Neoplasms; Piperazines; Pubic Bone; Pyrimidines; Stomach Neoplasms	2014
[A case of multiple liver metastases after resection of gastrointestinal stromal tumor of the small intestine that was successfully treated with imatinib mesylate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Aged; Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestine, Small; Liver Neoplasms; Male; Piperazines; Pyrimidines; Treatment Outcome	2013
[A case of liver and bone metastasis from gastrointestinal stromal tumor treated using imatinib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:1 Topics: Aged; Antineoplastic Agents; Benzamides; Bone Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Positron-Emission Tomography; Pyrimidines; Recurrence; Stomach Neoplasms	2014
The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastases. European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:5 Topics: Benzamides; Cohort Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Observer Variation; Outcome Assessment, Health Care; Piperazines; Pyrimidines; Time Factors; Tomography, X-Ray Computed; Tumor Burden	2014
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study). European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2014, Volume: 40, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Confounding Factors, Epidemiologic; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Liver Neoplasms; Male; Metastasectomy; Middle Aged; Patient Selection; Peritoneal Neoplasms; Piperazines; Predictive Value of Tests; Prognosis; Pyrimidines; Retrospective Studies; Risk Assessment; Risk Factors; Selection Bias; Treatment Outcome	2014
Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma. Clinical & experimental metastasis, 2014, Volume: 31, Issue:5 Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression; Humans; Imatinib Mesylate; Liver Neoplasms; Melanoma; Neoplasm Metastasis; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Stem Cell Factor; Treatment Outcome; Uveal Neoplasms	2014
[A case report of two-term surgery for focal progression of a huge liver metastasis and peritoneal dissemination from gastrointestinal stromal tumor during imatinib mesylate treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:3 Topics: Antineoplastic Agents; Benzamides; Disease Progression; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Stomach Neoplasms	2014
[Treatment strategy for recurrent and metastatic gastrointestinal stromal tumors]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2014, Volume: 17, Issue:4 Topics: Benzamides; Disease-Free Survival; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Indazoles; Indoles; Liver Neoplasms; Phenylurea Compounds; Piperazines; Pyridines; Pyrimidines; Pyrroles; Recurrence; Sulfonamides; Sunitinib	2014
Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab. Journal of proteome research, 2014, Jun-06, Volume: 13, Issue:6 Topics: Adenocarcinoma; Antibodies, Monoclonal; Antineoplastic Agents; Benzamides; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cluster Analysis; Colorectal Neoplasms; Feasibility Studies; Humans; Imatinib Mesylate; Liver Neoplasms; Panitumumab; Patient Selection; Phosphorylation; Pilot Projects; Piperazines; Precision Medicine; Prospective Studies; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Signal Transduction	2014
Important role of CYP2J2 in protein kinase inhibitor degradation: a possible role in intratumor drug disposition and resistance. PloS one, 2014, Volume: 9, Issue:5 Topics: Benzamides; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dasatinib; Hep G2 Cells; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Sorafenib; Sunitinib; Thiazoles	2014
Giant esophageal gastrointestinal stromal tumor: report of a case. Surgery today, 2015, Volume: 45, Issue:2 Topics: Aged; Benzamides; Endoscopy, Gastrointestinal; Esophageal Neoplasms; Esophagectomy; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Plastic Surgery Procedures; Pyrimidines; Thoracotomy; Treatment Outcome	2015
Unexpected DOG-1 immunoreactivity in sarcomatous carcinoma of the liver: a diagnostic pitfall. Pathology, 2014, Volume: 46, Issue:6 Topics: Aged; Anoctamin-1; Antineoplastic Agents; Autopsy; Bile Duct Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Chloride Channels; Diagnosis, Differential; Fatal Outcome; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Male; Neoplasm Proteins; Sarcoma; Tomography, X-Ray Computed; Ultrasonography	2014
Hepatic artery embolization for liver metastasis of gastrointestinal stromal tumor following imatinib and sunitinib therapy. Journal of gastrointestinal cancer, 2014, Volume: 45, Issue:4 Topics: Adult; Aged; Benzamides; Disease-Free Survival; Drug Resistance, Neoplasm; Embolization, Therapeutic; Female; Gastrointestinal Stromal Tumors; Hepatic Artery; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Male; Middle Aged; Piperazines; Prognosis; Pyrimidines; Pyrroles; Retrospective Studies; Sunitinib; Survival Analysis; Treatment Outcome	2014
Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour. ANZ journal of surgery, 2014, Volume: 84, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Piperazines; Pyrimidines; Retrospective Studies; Survival Analysis; Treatment Outcome	2014
Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor. Clinics (Sao Paulo, Brazil), 2014, Volume: 69, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Piperazines; Preoperative Care; Preoperative Period; Pyrimidines; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden	2014
[A case of recurrent duodenal gastrointestinal stromal tumor resistant to imatinib and sunitinib, successfully treated with regorafenib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Drug Resistance, Neoplasm; Duodenal Neoplasms; Fatal Outcome; Female; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Middle Aged; Phenylurea Compounds; Piperazines; Pyridines; Pyrimidines; Pyrroles; Recurrence; Sunitinib; Treatment Outcome	2014
[A case of giant gastric GIST with multiple hepatic metastases with long-term survival after multimodal therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antineoplastic Agents; Benzamides; Catheter Ablation; Combined Modality Therapy; Gastrectomy; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Pyrimidines; Stomach Neoplasms	2014
[A case of recurrent gastrointestinal stromal tumor progressing after interruption of long-term imatinib therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antineoplastic Agents; Benzamides; Disease Progression; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines; Recurrence; Stomach Neoplasms; Time Factors	2014
Primary gastrointestinal stromal tumor of the liver treated with sequential therapy. World journal of gastroenterology, 2015, Feb-28, Volume: 21, Issue:8 Topics: Aged; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Biopsy; Chemotherapy, Adjuvant; DNA Mutational Analysis; Drug Substitution; Female; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Immunohistochemistry; Indoles; Liver Neoplasms; Mutation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sunitinib; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2015
Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2015, Volume: 19, Issue:8 Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Databases, Factual; Disease-Free Survival; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leiomyosarcoma; Liver Neoplasms; Male; Metastasectomy; Middle Aged; Retroperitoneal Neoplasms; Retrospective Studies; Sarcoma; Survival Rate; Young Adult	2015
(15)O-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:8 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Benzamides; Colorectal Neoplasms; Female; Humans; Imatinib Mesylate; Interleukin 1 Receptor Antagonist Protein; Kinetics; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Oxygen Radioisotopes; Perfusion; Piperazines; Positron-Emission Tomography; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Reproducibility of Results; Time Factors; Water	2015
Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes. Journal of virology, 2015, Volume: 89, Issue:22 Topics: Animals; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cyclic S-Oxides; Dasatinib; Epithelial-Mesenchymal Transition; Female; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Imatinib Mesylate; Liver Neoplasms; Mice; Neoplasm Transplantation; Neoplastic Stem Cells; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-kit; RNA, Messenger; Sorafenib; Spheroids, Cellular; STAT3 Transcription Factor; Transplantation, Heterologous; Tumor Cells, Cultured	2015
Gastrointestinal stromal tumour metastatic to the epididymis. BMJ case reports, 2015, Sep-23, Volume: 2015 Topics: Antineoplastic Agents; Epididymis; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Genital Neoplasms, Male; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Pyridines; Scrotum; Tomography, X-Ray Computed	2015
Primary surgery as a frontline treatment for synchronous metastatic gastrointestinal stromal tumors: an analysis of the Kinki GIST registry. Surgery today, 2016, Volume: 46, Issue:9 Topics: Aged; Catheter Ablation; Combined Modality Therapy; Digestive System Surgical Procedures; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Japan; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Protein Kinase Inhibitors; Registries; Retrospective Studies; Survival Rate; Treatment Outcome	2016
[A Case of Intraductal Growth Pattern Gastrointestinal Stromal Tumor of the Stomach That Was Difficult to Diagnose by Biopsy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Aged; Antineoplastic Agents; Biopsy; Drug Combinations; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Oxonic Acid; Stomach Neoplasms; Tegafur	2015
[A Case of Multiple Liver Metastases and Peritoneal Dissemination after Resection of a Gastrointestinal Stromal Tumor of the Stomach Successfully Treated with Imatinib Mesylate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Aged; Antineoplastic Agents; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms	2015
Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2016, Volume: 42, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Liver Neoplasms; Male; Metastasectomy; Middle Aged; Netherlands; Proportional Hazards Models; Retrospective Studies; Survival Rate	2016
Role of metastasectomy for recurrent/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki GIST registry. Surgery today, 2017, Volume: 47, Issue:1 Topics: Aged; Antineoplastic Agents; Combined Modality Therapy; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Japan; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Protein Kinase Inhibitors; Registries; Retrospective Studies; Survival Rate; Time Factors	2017
A huge necrotic liver mass in a 45-year-old woman: delayed hepatic metastasis of a gastrointestinal stromal tumor. The Korean journal of internal medicine, 2017, Volume: 32, Issue:2 Topics: Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Intestinal Neoplasms; Liver Neoplasms; Middle Aged; Necrosis; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Time Factors; Treatment Outcome; Tumor Burden	2017
[Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2016, Nov-25, Volume: 19, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; China; Combined Modality Therapy; Exons; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Proto-Oncogene Proteins c-kit; Pyrroles; Retrospective Studies; Sunitinib; Survival Rate; Young Adult	2016
A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition. British journal of cancer, 2017, Feb-28, Volume: 116, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cell Line, Tumor; Collagen Type IV; Colorectal Neoplasms; Extracellular Matrix; Humans; Imatinib Mesylate; Liver Neoplasms; Mice; Treatment Outcome; Xenograft Model Antitumor Assays	2017
[Low-Dose and Interval Administration of Imatinib in a Patient with Liver Metastasis of the Gastrointestinal Stromal Tumor of the Stomach - A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:2 Topics: Aged; Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Recurrence; Stomach Neoplasms; Treatment Outcome	2017
Functional clustering of metastasis proteins describes plastic adaptation resources of breast-cancer cells to new microenvironments. Journal of proteome research, 2008, Volume: 7, Issue:8 Topics: Animals; Antineoplastic Agents; Benzamides; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cluster Analysis; Computational Biology; Electrophoresis, Gel, Two-Dimensional; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Organ Specificity; Piperazines; Protein Interaction Mapping; Protein-Tyrosine Kinases; Proteome; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transplantation, Heterologous	2008
Pathologic complete response confirmed by surgical resection for liver metastases of gastrointestinal stromal tumor after treatment with imatinib mesylate. World journal of gastroenterology, 2008, Jun-21, Volume: 14, Issue:23 Topics: Administration, Oral; Adult; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrectomy; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome	2008
Impact of different anticancer regimens on biomarkers of angiogenesis in patients with advanced hepatocellular cancer. Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:2 Topics: Aged; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Carcinoma, Hepatocellular; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Octreotide; Organoplatinum Compounds; Oxaliplatin; Piperazines; Pyrimidines; Randomized Controlled Trials as Topic; Survival Analysis	2009
Moving targets in hepatocellular carcinoma: hepatic progenitor cells as novel targets for tyrosine kinase inhibitors. Gastroenterology, 2008, Volume: 135, Issue:3 Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Hepatocytes; Humans; Imatinib Mesylate; Liver Neoplasms; Mice; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Stem Cells	2008
Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor. Archives of dermatology, 2008, Volume: 144, Issue:10 Topics: Benzamides; Biopsy, Needle; Drug Eruptions; Erythema; Follow-Up Studies; Foot Dermatoses; Gastrointestinal Stromal Tumors; Hand Dermatoses; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Piperazines; Protein Kinase Inhibitors; Pyloric Antrum; Pyrimidines; Risk Assessment; Stomach Neoplasms; Syndrome	2008
[A resected case of postoperative liver metastasis of a gastrointestinal stromal tumor showing complete response after imatinib treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:11 Topics: Aged; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Positron-Emission Tomography; Pyrimidines; Tomography, X-Ray Computed	2008
Sonography of multifocal Brucella orchitis. Ultraschall in der Medizin (Stuttgart, Germany : 1980), 2008, Volume: 29 Suppl 5 Topics: Adult; Antineoplastic Agents; Benzamides; Brucellosis; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Hemangioma; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Piperazines; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography	2008
Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2008, Volume: 19, Issue:2 Topics: Aged; Antineoplastic Agents; Benzamides; Colon; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Liver; Liver Neoplasms; Male; Neoplasm Invasiveness; Piperazines; Pyrimidines; Stomach; Stomach Neoplasms; Ultrasonography	2008
Dasatinib induces a response in chronic lymphocytic leukemia. Blood, 2009, Jan-08, Volume: 113, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blood Cell Count; Dasatinib; Female; Fusion Proteins, bcr-abl; Hemorrhage; Humans; Imatinib Mesylate; Jejunal Diseases; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Remission Induction; Rituximab; src-Family Kinases; Thiazoles; Tomography, X-Ray Computed; Vidarabine	2009
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib. Endoscopy, 2009, Volume: 41 Suppl 2 Topics: Benzamides; Biopsy, Needle; Chemotherapy, Adjuvant; Esophagitis; Esophagoscopy; Follow-Up Studies; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Piperazines; Pyrimidines; Risk Assessment; Severity of Illness Index; Stomach Neoplasms; Tomography, X-Ray Computed	2009
Cystic hepatic metastasis from gastrointestinal stromal tumor prior to imatinib mimicking a liver abscess. Journal of gastrointestinal and liver diseases : JGLD, 2009, Volume: 18, Issue:1 Topics: Antineoplastic Agents; Benzamides; Biopsy; Cysts; Diagnosis, Differential; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Abscess; Liver Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2009
The therapeutic benefits of heme oxygenase (HO-1) inhibition in the management of systemic malignancies besides hepatocellular carcinomas. International journal of cancer, 2009, Aug-01, Volume: 125, Issue:3 Topics: Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Enzyme Inhibitors; Heme Oxygenase-1; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Neoplasms; Nasopharyngeal Neoplasms; Neoplasms; Piperazines; Protoporphyrins; Pyrimidines; Sarcoma, Kaposi	2009
[Imaging of gastrointestinal stromal tumors]. Journal de radiologie, 2009, Volume: 90, Issue:4 Topics: Adult; Aged; Angiography; Antineoplastic Agents; Benzamides; Biopsy; Capsule Endoscopy; Contrast Media; Diagnosis, Differential; Endosonography; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Pyrimidines; Recurrence; Tomography, X-Ray Computed; Treatment Outcome	2009
Incomplete Carney triad--a review of two cases. QJM : monthly journal of the Association of Physicians, 2009, Volume: 102, Issue:9 Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Benzamides; Bronchial Diseases; Chondroma; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Neoplasms, Multiple Primary; Paraganglioma, Extra-Adrenal; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2009
Primary large gastrointestinal stromal tumor of the liver: report of a case. Surgery today, 2009, Volume: 39, Issue:7 Topics: Adult; Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Reoperation; Skin Neoplasms; Stomach Neoplasms	2009
Gastrointestinal stromal tumor of the stomach with extremely slow-growing hematogenous metastasis. International journal of clinical oncology, 2009, Volume: 14, Issue:3 Topics: Aged; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Piperazines; Pyrimidines; Stomach Neoplasms	2009
Residual and recurrent gastrointestinal stromal tumors with KIT mutations: findings at first follow-up CT after imatinib treatment. AJR. American journal of roentgenology, 2009, Volume: 193, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Benzamides; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplasm, Residual; Peptide Fragments; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Retrospective Studies; Splenic Neoplasms; Tomography, X-Ray Computed	2009
[Imaging follow-up of gastrointestinal stromal tumors (GIST) during therapy: a case report]. Journal de radiologie, 2009, Volume: 90, Issue:6 Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Contrast Media; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Ileum; Imatinib Mesylate; Liver Neoplasms; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2009
Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. American journal of clinical oncology, 2009, Volume: 32, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Embolization, Therapeutic; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatic Artery; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Piperazines; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Retrospective Studies; Survival Rate; Treatment Outcome	2009
[GIST: Imaging diagnosis, staging, and response assessment]. Wiener medizinische Wochenschrift (1946), 2009, Volume: 159, Issue:15-16 Topics: Antineoplastic Agents; Benzamides; Biopsy; Colonic Neoplasms; Contrast Media; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Image Processing, Computer-Assisted; Imatinib Mesylate; Liver Neoplasms; Neoplasm Staging; Piperazines; Positron-Emission Tomography; Pyrimidines; Sensitivity and Specificity; Stomach Neoplasms; Tomography, Spiral Computed	2009
[A successfully resected case of liver metastasis of gastrointestinal stromal tumor responding to neoadjuvant chemotherapy with imatinib mesylate and interventional radiology]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:10 Topics: Aged; Antineoplastic Agents; Benzamides; Catheter Ablation; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Neoadjuvant Therapy; Piperazines; Pyrimidines; Radiology, Interventional	2009
[Long-term survival after surgery and adjuvant imatinib in a patient with rectal GIST, local recurrence, liver metastases and mediastinal pleural metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12 Topics: Administration, Oral; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Mediastinum; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pleural Neoplasms; Pyrimidines; Rectal Neoplasms	2009
[Successful treatment of a gastrointestinal stromal tumor with liver metastases in a case that tolerated imatinib administration, by radiofrequency ablation using contrast-enhanced ultrasonography]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2010, Volume: 107, Issue:3 Topics: Adult; Antineoplastic Agents; Benzamides; Catheter Ablation; Contrast Media; Drug Tolerance; Female; Ferric Compounds; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Iron; Liver Neoplasms; Oxides; Piperazines; Pyrimidines; Ultrasonography	2010
A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome. BMC cancer, 2010, May-13, Volume: 10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Chi-Square Distribution; Disease Progression; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Prospective Studies; Protein Kinase Inhibitors; Pyrimidines; Time Factors; Treatment Outcome; Young Adult	2010
Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2011, Volume: 17, Issue:3 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Biopsy; Gastrointestinal Stromal Tumors; Histamine Antagonists; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Keratoderma, Palmoplantar; Liver Neoplasms; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Rosacea; Skin; Skin Pigmentation; Sunitinib; Treatment Outcome	2011
A novel primary KIT exon 9 single nucleotide substitution c.1427G>T (p.Ser476Ile) in a gastrointestinal stromal tumor. Virchows Archiv : an international journal of pathology, 2010, Volume: 457, Issue:5 Topics: Adult; Antineoplastic Agents; Base Sequence; Benzamides; Combined Modality Therapy; Digestive System Surgical Procedures; Disease Progression; Exons; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Male; Molecular Sequence Data; Peritoneal Neoplasms; Piperazines; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Sunitinib	2010
Response to nilotinib as a first-line treatment for metastatic gastrointestinal stromal tumors. Journal of gastrointestinal cancer, 2012, Volume: 43, Issue:2 Topics: Adult; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Peritoneal Neoplasms; Piperazines; Positron-Emission Tomography; Pyrimidines	2012
Small gastrointestinal stromal tumor of the stomach showing rapid growth and early metastasis to the liver. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2010, Volume: 22, Issue:4 Topics: Aged; Antineoplastic Agents; Benzamides; Endoscopy, Gastrointestinal; Fatal Outcome; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Pyrimidines; Stomach Neoplasms	2010
[Usefulness of low-dose and long-term administration of imatinib in patients with liver metastases of rectal GIST and GIST of stomach]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12 Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines; Rectal Neoplasms; Stomach Neoplasms	2010
Metastatic uterine leiomyosarcoma and eosinophilia. Obstetrics and gynecology, 2011, Volume: 117, Issue:2 Pt 2 Topics: Antineoplastic Agents; Benzamides; Dyspnea; Eosinophilia; Fatal Outcome; Female; Humans; Hydroxyurea; Imatinib Mesylate; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Middle Aged; Piperazines; Prednisone; Pyrimidines; Splenic Neoplasms; Uterine Neoplasms	2011
Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors. International journal of clinical oncology, 2011, Volume: 16, Issue:6 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Male; Mutation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Radiography; Sunitinib	2011
A case of hepatic metastasis from gastric GIST successfully resected following neoadjuvant targeted therapy. Japanese journal of clinical oncology, 2011, Volume: 41, Issue:4 Topics: Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Jaundice, Obstructive; Liver Neoplasms; Molecular Targeted Therapy; Neoadjuvant Therapy; Piperazines; Pyrimidines; Stomach Neoplasms	2011
[A case of imatinib-resistant GIST treated by sunitinib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:5 Topics: Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines; Pyrroles; Quality of Life; Sunitinib; Tomography, X-Ray Computed	2011
Dasatinib, imatinib and staurosporine capture compounds - Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS). Journal of proteomics, 2011, Dec-10, Volume: 75, Issue:1 Topics: Benzamides; Chromatography, Liquid; Dasatinib; Gene Expression Profiling; Hep G2 Cells; Humans; Imatinib Mesylate; Liver Neoplasms; Mass Spectrometry; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Pyrimidines; Staurosporine; Thiazoles	2011
Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: report of a case. Surgery today, 2011, Volume: 41, Issue:9 Topics: Abdominal Neoplasms; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Connective Tissue; Neoplasms, Multiple Primary; Piperazines; Pyrimidines	2011
Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib. Annals of surgical oncology, 2012, Volume: 19, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzenesulfonates; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Niacinamide; Phenylurea Compounds; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyridines; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Retrospective Studies; Risk Factors; Serum Albumin; Sorafenib; Sunitinib; Survival Rate; Young Adult	2012
[Clinical analysis of 79 gastrointestinal tract stromal tumor cases]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines	2011
[Hepatic metastasis from gastric GIST radically resected after imatinib mesylate therapy-a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12 Topics: Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Neoadjuvant Therapy; Piperazines; Pyrimidines; Stomach Neoplasms; Tomography, X-Ray Computed	2011
Intracranial metastasis from pediatric GI stromal tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Apr-01, Volume: 30, Issue:10 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzenesulfonates; Brain Neoplasms; Drug Administration Schedule; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Piperazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Sorafenib; Stomach Neoplasms; Sunitinib; Treatment Outcome	2012
[A case of long survival after resection and treatment with imatinib mesylate against metachronous liver metastases and a lung metastasis of a small intestine gastrointestinal stromal tumor]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Liver Neoplasms; Lung Neoplasms; Male; Piperazines; Pyrimidines; Time Factors; Tomography, X-Ray Computed	2012
[Long-term progression-free survival after reduction surgery and postoperative low-dose imatinib administration for multiple liver metastases of duodenal gastrointestinal stromal tumor]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:6 Topics: Antineoplastic Agents; Benzamides; Combined Modality Therapy; Disease-Free Survival; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2012
Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. International journal of cancer, 2013, Feb-15, Volume: 132, Issue:4 Topics: Animals; Apoptosis; Benzamides; Bone Marrow Cells; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Piperazines; Pyrimidines; Random Allocation; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Transplantation, Heterologous; Tumor Microenvironment	2013
A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Oct-15, Volume: 18, Issue:20 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Piperazines; Prospective Studies; Pyrimidines	2012
Therapeutic drug monitoring of imatinib--new data strengthen the case. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Oct-15, Volume: 18, Issue:20 Topics: Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Pyrimidines	2012
Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:4 Topics: Aged; Animals; Antigens, Neoplasm; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Adhesion Molecules; Cell Line, Tumor; Endothelium, Vascular; Epithelial Cell Adhesion Molecule; Epithelial Cells; Female; Humans; Imatinib Mesylate; In Vitro Techniques; Liver Neoplasms; Male; Mice; Mice, SCID; Middle Aged; Neoplastic Stem Cells; Piperazines; Pyrimidines; Thy-1 Antigens; Transplantation, Heterologous	2013
Pregnancy with metastatic gastrointestinal stromal tumor (GIST) on imatinib chemotherapy: an oncologist's nightmare and obstetrician's dilemma. Journal of gastrointestinal cancer, 2013, Volume: 44, Issue:1 Topics: Adult; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Physician's Role; Piperazines; Pregnancy; Pregnancy Complications, Neoplastic; Pyrimidines; Remission Induction; Treatment Outcome	2013
[A case of drug resistant recurrent gastrointestinal stromal tumor treated surgically by resection, partial hepatectomy and diaphragmectomy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Diaphragm; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Indoles; Jejunal Neoplasms; Liver Neoplasms; Male; Peritoneal Neoplasms; Piperazines; Pyrimidines; Pyrroles; Recurrence; Sunitinib	2012
Severe hemolytic anemia and skin reaction in a patient treated with imatinib. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:6 Topics: Adrenal Gland Neoplasms; Anemia, Hemolytic; Antineoplastic Agents; Benzamides; Exanthema; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Piperazines; Pyrimidines; Risk Factors; Splenic Neoplasms; Stomach Neoplasms	2003
[Metastatic gastrointestinal stromal tumors responded to the treatment with STI571 after polysurgery for recurrent lesions--report of two cases]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:7 Topics: Administration, Oral; Benzamides; Combined Modality Therapy; Drug Administration Schedule; Female; Gastrectomy; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Stomach Neoplasms; Stromal Cells	2003
F-18 FDG PET imaging in gastrointestinal stromal tumor. Clinical nuclear medicine, 2003, Volume: 28, Issue:8 Topics: Antineoplastic Agents; Benzamides; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Pyrimidines; Radiopharmaceuticals; Stromal Cells; Tomography, Emission-Computed; Whole-Body Counting	2003
Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor. Journal of gastroenterology, 2003, Volume: 38, Issue:7 Topics: Antineoplastic Agents; Benzamides; Duodenal Neoplasms; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2003
Case 3. Resection of originally inoperable liver metastases of gastrointestinal stromal tumor after imatinib mesylate therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-15, Volume: 21, Issue:18 Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Jejunal Neoplasms; Liver Neoplasms; Piperazines; Pyrimidines	2003
Imatinib administration in two patients with liver metastases from GIST and severe jaundice. British journal of cancer, 2003, Oct-20, Volume: 89, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Jaundice; Liver Neoplasms; Male; Piperazines; Pyrimidines; Stromal Cells; Treatment Outcome	2003
Treatment with STI571, a tyrosine kinase inhibitor, for gastrointestinal stromal tumor with peritoneal dissemination and multiple liver metastases. Journal of gastroenterology, 2003, Volume: 38, Issue:9 Topics: Adult; Benzamides; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Neoplasm Invasiveness; Neoplasms, Connective Tissue; Peritoneum; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2003
The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST). Neoplasma, 2003, Volume: 50, Issue:6 Topics: Adult; Aged; Benzamides; Combined Modality Therapy; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Hepatectomy; Humans; Imatinib Mesylate; Intestinal Neoplasms; Liver Neoplasms; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Reoperation; Retrospective Studies; Stomach Neoplasms; Time Factors; Tomography, X-Ray Computed	2003
[A patient with unresectable gastrointestinal stromal tumor responded to STI571]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2004, Volume: 101, Issue:4 Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Radiography, Abdominal; Stomach Neoplasms; Tomography, X-Ray Computed	2004
Thymic carcinoma with overexpression of mutated KIT and the response to imatinib. The New England journal of medicine, 2004, Jun-17, Volume: 350, Issue:25 Topics: Antineoplastic Agents; Benzamides; Bone Neoplasms; Disease Progression; Fatal Outcome; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sequence Analysis, DNA; Sequence Deletion; Thymoma; Thymus Neoplasms	2004
Gastrointestinal stromal tumors arising from the stomach: a report of three children. Journal of pediatric surgery, 2004, Volume: 39, Issue:10 Topics: Abdominal Pain; Anemia; Benzamides; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Follow-Up Studies; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Laparotomy; Liver Neoplasms; Male; Piperazines; Pyrimidines; Radiography; Stomach Neoplasms	2004
Combined liver transplantation plus imatinib for unresectable metastases of gastrointestinal stromal tumours. European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:11 Topics: Adult; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Female; Humans; Imatinib Mesylate; Leiomyosarcoma; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Treatment Outcome	2004
[Two cases of postoperative recurrence of gastric GIST treated by imatinib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:10 Topics: Antineoplastic Agents; Benzamides; Combined Modality Therapy; Drug Administration Schedule; Female; Gastrectomy; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Stomach Neoplasms; Thyroid Neoplasms	2004
Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene. Journal of gastroenterology, 2004, Volume: 39, Issue:9 Topics: Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Tomography, X-Ray Computed	2004
A treatment using STI571 for jejunal gastrointestinal stromal tumor (GIST) accompanied with liver metastasis and peritoneal dissemination. Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:12 Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2004
Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case. Surgery today, 2005, Volume: 35, Issue:2 Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2005
Gastrointestinal stromal tumor of the prostate. Urology, 2005, Volume: 65, Issue:2 Topics: Acute Disease; Amino Acid Substitution; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Mutation, Missense; Neoplasm Proteins; Piperazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiography; Sarcoma; Urinary Retention; Weight Loss	2005
Malignant gastrointestinal stromal tumor of the small intestine complicated with pulmonary tuberculosis during treatment with imatinib mesylate. Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:2 Topics: Administration, Oral; Antineoplastic Agents; Antitubercular Agents; Benzamides; Combined Modality Therapy; Digestive System Surgical Procedures; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Laparotomy; Leiomyosarcoma; Liver Neoplasms; Male; Middle Aged; Neutropenia; Piperazines; Pyrimidines; Tomography, X-Ray Computed; Tuberculosis, Pulmonary	2005
Gastrointestinal stromal tumors: CT and MRI findings. European radiology, 2005, Volume: 15, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Image Enhancement; Imatinib Mesylate; Intestine, Small; Liver Neoplasms; Magnetic Resonance Imaging; Male; Mesentery; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Radiographic Image Enhancement; Rectal Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed	2005
[Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2004, Volume: 26, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Edema; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Piperazines; Pyrimidines; Remission Induction; Survival Rate	2004
Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients. European journal of radiology, 2005, Volume: 54, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Contrast Media; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Iohexol; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Prospective Studies; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome	2005
Clinical benefit of intermittent administration of imatinib in a patient with metastatic gastrointestinal stromal tumour. Clinical oncology (Royal College of Radiologists (Great Britain)), 2005, Volume: 17, Issue:2 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2005
Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study. Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:4 Topics: Adult; Antineoplastic Agents; Area Under Curve; Benzamides; Female; Half-Life; Humans; Imatinib Mesylate; Kidney Failure, Chronic; Liver Neoplasms; Piperazines; Pyrimidines; Renal Dialysis	2005
Carcinosarcoma of the liver: a case report and review of the literature. Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:6 Topics: Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Carcinosarcoma; Diagnosis, Differential; Fatal Outcome; Female; Hepatorenal Syndrome; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Piperazines; Pyrimidines; Sarcoma	2005
An omental mass: any hypothesis? Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2005, Volume: 7, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Digestive System Surgical Procedures; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Omentum; Peritoneal Neoplasms; Piperazines; Pyrimidines; Splenic Neoplasms; Tomography, X-Ray Computed	2005
Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Sep-01, Volume: 11, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Tomography, X-Ray Computed; Ultrasonography; Vascular Endothelial Growth Factor A	2005
Primary gastrointestinal stromal tumor of the liver with lung metastases successfully treated with STI-571 (imatinib mesylate). Frontiers in bioscience : a journal and virtual library, 2006, Jan-01, Volume: 11 Topics: Adult; Antineoplastic Agents; Benzamides; Cell Differentiation; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Neoplasm Metastasis; Phenotype; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Tissue Distribution; Tomography, X-Ray Computed; Treatment Outcome; Vimentin	2006
Complete remission with imatinib in metastastic gastrointestinal stromal tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-20, Volume: 23, Issue:27 Topics: Benzamides; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Piperazines; Pyrimidines; Treatment Outcome	2005
[A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11 Topics: Adult; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Pancreaticoduodenectomy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome	2005
Thymic carcinoma in a child with HIV infection. Pediatric blood & cancer, 2007, Volume: 49, Issue:7 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Child; Disease Progression; Follow-Up Studies; HIV Infections; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Male; Mediastinal Cyst; Piperazines; Pyrimidines; Remission Induction; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2007
Pathological complete response in advanced gastrointestinal stromal tumor after imatinib therapy. Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:11 Topics: Antineoplastic Agents; Benzamides; Follow-Up Studies; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Stomach; Tomography, X-Ray Computed	2005
Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Dec-15, Volume: 11, Issue:24 Pt 1 Topics: Animals; Benzamides; Carcinoma, Hepatocellular; Cell Proliferation; Endothelium, Vascular; Gene Expression Profiling; Humans; Imatinib Mesylate; Interferon-alpha; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Transcriptional Activation	2005
Immunohistochemical and genetic features of gastric and metastatic liver gastrointestinal stromal tumors: sequential analyses. Cancer science, 2006, Volume: 97, Issue:2 Topics: Aged; Amino Acid Sequence; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Liver Neoplasms; Loss of Heterozygosity; Male; Microsatellite Repeats; Middle Aged; Molecular Sequence Data; Neoplasm Proteins; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sequence Homology, Amino Acid; Stomach Neoplasms	2006
Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy. World journal of gastroenterology, 2006, May-07, Volume: 12, Issue:17 Topics: Adult; Antineoplastic Agents; Benzamides; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Survivors	2006
Efficacy of imatinib mesylate in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy with epirubicin. Journal of experimental & clinical cancer research : CR, 2003, Volume: 22, Issue:4 Suppl Topics: Aged; Antineoplastic Agents; Benzamides; Epirubicin; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines	2003
[A gastric stromal tumor (GIST) with a prolonged partial response to a reduced dose of imatinib mesilate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:7 Topics: Aged; Anemia; Antineoplastic Agents; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leukopenia; Liver Neoplasms; Piperazines; Pyrimidines; Stomach Neoplasms	2006
Response evaluation in gastrointestinal stromal tumours treated with imatinib: misdiagnosis of disease progression on CT due to cystic change in liver metastases. The British journal of radiology, 2006, Volume: 79, Issue:944 Topics: Aged; Antineoplastic Agents; Benzamides; Cysts; Diagnostic Errors; Disease Progression; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2006
Treatment of metastatic sarcoma to the liver with bland embolization. Cancer, 2006, Oct-01, Volume: 107, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Chemoembolization, Therapeutic; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Piperazines; Polyvinyl Alcohol; Pyrimidines; Sarcoma; Treatment Outcome	2006
Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era. Annals of surgical oncology, 2006, Volume: 13, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; Disease-Free Survival; Feasibility Studies; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Medical Records; Middle Aged; Necrosis; Peritoneal Neoplasms; Piperazines; Preoperative Care; Protein-Tyrosine Kinases; Pyrimidines; Retrospective Studies; Survival Rate	2006
Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis. Saudi medical journal, 2006, Volume: 27, Issue:10 Topics: Antineoplastic Agents; Benzamides; Colitis, Ulcerative; Gastrointestinal Stromal Tumors; Humans; Hypercalcemia; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rectum; Treatment Outcome	2006
Sunitinib for imatinib-resistant GIST. Lancet (London, England), 2006, Oct-14, Volume: 368, Issue:9544 Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Multicenter Studies as Topic; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Sunitinib	2006
Malignant gastrointestinal stromal neoplasm. Surgery, 2006, Volume: 140, Issue:5 Topics: Adult; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Pyrimidines; Sarcoma	2006
[A case of gastrointestinal stromal tumor with liver and bone metastases effectively treated with radiofrequency ablation and imatinib mesylate]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2006, Volume: 103, Issue:11 Topics: Antineoplastic Agents; Benzamides; Bone Neoplasms; Catheter Ablation; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestine, Small; Liver Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines	2006
Imatinib mesylate inhibits proliferation and modulates cytokine expression of human cancer-associated stromal fibroblasts from colorectal metastases. Cancer letters, 2007, Jun-08, Volume: 250, Issue:2 Topics: Antineoplastic Agents; Base Sequence; Benzamides; Cell Proliferation; Colorectal Neoplasms; Culture Media, Conditioned; Cytokines; DNA Primers; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Pyrimidines; Stromal Cells	2007
[A case of recurrent GIST of the esophagus which completely responded to imatinib mesilate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:2 Topics: Aged; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Piperazines; Pyrimidines; Remission Induction; Skin Neoplasms	2007
CD117 (c-kit) expression in human hepatocellular carcinoma. Clinical oncology (Royal College of Radiologists (Great Britain)), 2007, Volume: 19, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Child; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Piperazines; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrimidines; Retrospective Studies	2007
Pathological and biomolecular analyses of colorectal endocrine carcinoma. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2007, Volume: 74, Issue:1 Topics: Benzamides; Carcinoma, Neuroendocrine; Cell Differentiation; Cell Line, Tumor; Colorectal Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Vascular Endothelial Growth Factor A	2007
Development of multiple myeloma in a patient with gastrointestinal stromal tumor treated with imatinib mesylate: a case report. World journal of gastroenterology, 2007, Apr-07, Volume: 13, Issue:13 Topics: Aged; Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Multiple Myeloma; Neoplasms, Multiple Primary; Piperazines; Pyrimidines	2007
Disease progression following imatinib failure in gastrointestinal stromal tumors: role of surgical therapy. The oncologist, 2007, Volume: 12, Issue:4 Topics: Adult; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Disease Progression; Fatal Outcome; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Neoplasm Metastasis; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Tomography, X-Ray Computed	2007
Effect of imatinib mesylate in a patient with a metastatic gastrointestinal stromal tumor with a c-kit mutation in exon 11. Digestive diseases and sciences, 2007, Volume: 52, Issue:7 Topics: Adult; Antineoplastic Agents; Benzamides; Exons; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sequence Deletion	2007
Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate. Anti-cancer drugs, 2007, Volume: 18, Issue:8 Topics: Antineoplastic Agents; Benzamides; Combined Modality Therapy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2007
Safety of imatinib in chronic myeloid leukemia in blastic crisis presenting as cholestatic jaundice. Acta haematologica, 2007, Volume: 118, Issue:3 Topics: Adult; Antineoplastic Agents; Benzamides; Blast Crisis; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Humans; Imatinib Mesylate; Jaundice, Obstructive; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Neoplasms; Male; Piperazines; Pyrimidines	2007
Lymphomatoid granulomatosis induced by imatinib-treatment. Archives of dermatology, 2007, Volume: 143, Issue:9 Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Diseases; Lymphomatoid Granulomatosis; Piperazines; Pyrimidines; Skin Diseases	2007
Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis. Differentiation; research in biological diversity, 2007, Volume: 75, Issue:9 Topics: Animals; Antigens, CD34; Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Cell Proliferation; Cell Transformation, Neoplastic; Imatinib Mesylate; Liver Cirrhosis; Liver Neoplasms; Lymphokines; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Rats; Receptor, Platelet-Derived Growth Factor alpha; Stromal Cells	2007
Locally advanced GISTs need aggressive therapy pending the results of trials. Annals of surgical oncology, 2008, Volume: 15, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines	2008
Surgical debulking of gastrointestinal stromal tumors: is it a reasonable option after second-line treatment with sunitinib? Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:5 Topics: Adult; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Digestive System Surgical Procedures; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Pyrroles; Sunitinib; Tomography, X-Ray Computed	2008
A multidisciplinary approach for the treatment of GIST liver metastasis. World journal of surgical oncology, 2008, May-09, Volume: 6 Topics: Aged; Benzamides; Combined Modality Therapy; Embolization, Therapeutic; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Pyrimidines	2008
Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection. Oncology, 2007, Volume: 73, Issue:5-6 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pilot Projects; Piperazines; Postoperative Complications; Pyrimidines	2007
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. The New England journal of medicine, 2001, Apr-05, Volume: 344, Issue:14 Topics: Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Female; Fluorodeoxyglucose F18; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma; Stomach Neoplasms; Stromal Cells; Tomography, Emission-Computed	2001
[A patient with metastatic gastrointestinal stromal tumor who responded to STI571]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:4 Topics: Adult; Antineoplastic Agents; Benzamides; Cell Division; Drug Administration Schedule; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Stomach Neoplasms	2002